XML 51 R38.htm IDEA: XBRL DOCUMENT v3.25.1
EARNINGS (LOSS) PER SHARE (Tables)
3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Loss Per Share, Basic and Diluted
The following tables set forth the calculation of basic and diluted earnings (loss) per share attributable to ordinary shareholders for the three months ended March 31, 2025 and 2024 (in thousands, except share and per share data):

Three Months Ended March 31, 2025
Basic EPS:
Numerator:
  Net income$7,893 
  Less: Undistributed earnings allocated to preferred shares489 
  Net income attributable to Pagaya Technologies Ltd. ordinary shareholders, basic$7,404 
Denominator:
  Weighted average shares used for earnings per ordinary share, basic75,765,080
  Earnings per share attributable to ordinary shareholders, basic$0.10 
Diluted EPS:
Numerator:
  Net income attributable to Pagaya Technologies Ltd. ordinary shareholders, diluted$7,404 
Denominator:
  Shares used in computation of basic earnings per share75,765,080 
  Ordinary share warrants 784,762
  Unvested RSUs473,300
  Ordinary shares upon employee stock purchase plan20,322
  Weighted average shares used for earnings per ordinary share, diluted77,043,464 
  Earnings per share attributable to ordinary shareholders, diluted$0.10 
Three Months Ended March 31, 2024
Numerator:
  Net loss attributable to Pagaya Technologies Ltd. ordinary shareholders, basic and diluted$(21,223)
Denominator:
  Weighted average shares used for net loss per ordinary share, basic and diluted64,504,458
  Net loss per share attributable to ordinary shareholders, basic and diluted$(0.33)
Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share
The following potentially dilutive outstanding securities as of March 31, 2025 and 2024 were excluded from the computation of diluted earnings (loss) per share because their effect would have been anti-dilutive for the periods: 

March 31,
20252024
Share options3,427,161 3,766,593 
Options to restricted shares19,923,756 20,034,514 
RSUs271,876 2,353,589 
Ordinary share warrants1,229,166 2,016,326 
Exchangeable notes(1)
11,434,704 — 
Net potential dilutive outstanding securities36,286,663 33,171,022 
(1) For the three months ended March 31, 2025, the potential shares from exchangeable notes were excluded from the diluted EPS calculation as the incremental interest expense, net of tax, and the related shares would not be dilutive under the if-converted method.